Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell Transplantation Recipient”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Not applicableUnknownNCT05692713
What this trial is testing

Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)

Who this might be right for
Chronic Graft-versus-Host-DiseaseAllogeneic Hematopoietic Stem Cell TransplantationLeukemia+2 more
University of British Columbia 320
Testing effectiveness (Phase 2)UnknownNCT01883219
What this trial is testing

TKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Who this might be right for
Philadelphia Chromosome Positive Acute Lymphocytic LeukemiaStem Cell TransplantationMinimal Residual Disease
Nanfang Hospital, Southern Medical University 80
Testing effectiveness (Phase 2)Study completedNCT04926194
What this trial is testing

Decidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative Neoplasm

Who this might be right for
Myelodysplastic/Myeloproliferative NeoplasmSteroid Refractory GVHDAllogeneic Hematopoietic Cell Transplant
University Health Network, Toronto 1
Testing effectiveness (Phase 2)Study completedNCT03267186
What this trial is testing

Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+2 more
Andrew Rezvani 8
Not applicableStudy completedNCT03889028
What this trial is testing

Pre-engraftment Cytomegalovirus DNAemia

Who this might be right for
CMV DNAemia Pre-engraftment
Fundación para la Investigación del Hospital Clínico de Valencia 878
Not applicableStudy completedNCT03401268
What this trial is testing

Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients

Who this might be right for
Hypogammaglobulinemia
University Health Network, Toronto 20
Large-scale testing (Phase 3)Looking for participantsNCT07583888
What this trial is testing

VABu Conditioning in Elderly AML HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientAcute Myeloid Leukemia (AML)
The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Study completedNCT00942305
What this trial is testing

Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
Cytomegalovirus Infection
Jazz Pharmaceuticals 239
Early research (Phase 1)Study completedNCT04220684
What this trial is testing

Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML

Who this might be right for
Allogeneic Stem Cell Transplant RecipientBlasts 10 Percent or More of Bone Marrow Nucleated CellsRecurrent Acute Myeloid Leukemia+1 more
Sumithira Vasu 19
Large-scale testing (Phase 3)Study completedNCT05763823
What this trial is testing

Letermovir (MK-8228) to Evaluate Efficacy and Safety for Prevention of Cytomegalovirus Infection in Chinese Hematopoietic Stem Cell Transplant Recipients (MK-8228-045)

Who this might be right for
Cytomegalovirus Infection
Merck Sharp & Dohme LLC 120
Large-scale testing (Phase 3)Study completedNCT00980655
What this trial is testing

Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
Vaccines, Pneumococcal Conjugate Vaccine
Pfizer 251
Testing effectiveness (Phase 2)Ended earlyNCT01135537
What this trial is testing

Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants

Who this might be right for
MalignancyMetabolic DiseaseGenetic Disorder
The Hospital for Sick Children 30
Testing effectiveness (Phase 2)WithdrawnNCT04127721
What this trial is testing

Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation

Who this might be right for
Allogeneic Stem Cell Transplant RecipientHematologic and Lymphocytic DisorderHematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center
Not applicableUnknownNCT05649371
What this trial is testing

Multiphasic Prehab Allo-HSCT

Who this might be right for
Leukemia
University of Calgary 60
Testing effectiveness (Phase 2)Ended earlyNCT02200380
What this trial is testing

A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs

Who this might be right for
For DonorsRelated Donors Giving Peripheral Blood Stem Cells (PBSC) to a SiblingFor Recipients+7 more
Celldex Therapeutics 36
Post-approval studies (Phase 4)Study completedNCT01335035
What this trial is testing

Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload

Who this might be right for
Iron Overload
Novartis Pharmaceuticals 30
Early research (Phase 1)Study completedNCT00423774
What this trial is testing

Education Program to Manage Emotional Stress of Stem Cell Transplant Recipients and Their Caregivers

Who this might be right for
Family CaregiversBone Marrow Transplantation
National Institutes of Health Clinical Center (CC) 20
Not applicableNot Yet RecruitingNCT07286461
What this trial is testing

VIROMARKERS GA n.101194735 - CMV and TTV Biomarkers Study Protocol

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientCMV
University of Rome Tor Vergata 290
Testing effectiveness (Phase 2)Ended earlyNCT01640301
What this trial is testing

Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Recurrent Adult Acute Myeloid LeukemiaRecurrent Childhood Acute Myeloid LeukemiaSecondary Acute Myeloid Leukemia+5 more
Fred Hutchinson Cancer Center 47
Early research (Phase 1)Study completedNCT01163357
What this trial is testing

Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant RecipientLoss of Chromosome 17pPlasma Cell Leukemia+2 more
City of Hope Medical Center 18
Next Page